Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Aug 10, 2026
Revenue (TTM)
$38.09B
+9.5% YoY
Gross margin
71.9%
EPS (latest q)
$6.29
vs $5.60 est · beat
52-wk position
100.0%
0.0% vs 52w high · +13.1% 1mo
Price (last ~year)
Amgen Inc. (AMGN) reported Q2 2026 revenue of $10.05 billion and net income of $2.38 billion, extending a streak of four consecutive earnings beats. The stock has gained 23.1% over the past three months to reach $410.94, currently trading at its 52-week high with a market capitalization of $222.32 billion. Supported by 9.5% year-over-year revenue growth and a 35.5% operating margin, the company carries $57.30 billion in total debt against $13.99 billion in cash.
Valuation
- Market cap
- $222.32B
- P/E
- 25.51
- PEG
- 2.157
- P/B
- 19.02
- P/S
- 5.84
- EV/EBITDA
- 15.07
- Beta
- 0.413
- Analyst target
- $374.69
Quality & returns
- Gross margin
- 71.9%
- Operating margin
- 35.5%
- Profit margin
- 23.0%
- ROE
- 91.5%
- ROA
- 8.7%
Price movement
- Last
- $410.94
- 1-month
- +13.1%
- 3-month
- +23.1%
- RSI (14)
- 79
- vs SMA200
- +19.7%
- 52-wk position
- 100.0% 0.0% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $10.05B | $3.51B | $2.38B | $3.44B |
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
Recent news
- Somewhat-Bullish Erste Group Bank Brokers Lower Earnings Estimates for Amgen · 2026-08-10
- Somewhat-Bullish Amgen Inc. (AMGN) Stock forecasts · 2026-08-09
- Neutral Did Alkermes’ (ALKS) Profit Slide and Cash-Conserving Moves Just Shift Its Investment Narrative? · 2026-08-09
- Somewhat-Bullish Avity Investment Management Inc. Has $27.59 Million Stock Holdings in Amgen Inc. $AMGN · 2026-08-09
- Somewhat-Bullish Cardano Risk Management B.V. Sells 14,358 Shares of Amgen Inc. $AMGN · 2026-08-09
- Neutral Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors? · 2026-08-09
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)